Medina, Baby Girl .

HRN: 29-18-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/22/2026
06/28/2026
IV
45mg
OD
Prom X 18hrs
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: